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In 2011 NHS England commissioned a new national specialist MDT service for patients and families affected by Stickler syndrome.
The Stickler syndromes form part of the spectrum of inherited vitreoretinopathies and are the most common cause of retinal
detachment in childhood and the most common cause of familial retinal detachment. Now in its 10th year, the Stickler Highly
Specialised Service (HSS) has assessed 1673 patients from 785 families. Using a combination of accurate phenotyping and
molecular genetic analysis it is possible to identify the underlying genetic mutation in over 95% of cases including those with deep
intronic mutations likely to be missed by conventional exome panel analysis and which require whole gene sequencing and
supplementary functional analysis to confirm pathogenicity. The vast majority that presents to ophthalmologists will be from one of
three autosomal dominant sub-groups with a high associated risk of retinal detachment but the diagnosis is often overlooked,
especially in adults. In contrast to many other blinding retinal conditions, blindness through giant retinal tear detachment
particularly in children is largely preventable provided these high-risk groups are identified and appropriate evidence-based




In 2011 NHS England commissioned a new national specialist MDT
service for patients and families affected by Stickler syndrome. The
Stickler syndromes form part of the spectrum of inherited
vitreoretinopathies and are the most common cause of retinal
detachment in childhood and the most common cause of familial
retinal detachment. Initially considered a mono-genic disorder, at
least 10 clinically and genetically distinct sub-groups of Stickler
syndrome are now recognised (Table 1) [1]. The principal clinical
features are congenital myopia, retinal detachment, deafness, cleft
palate and premature arthropathy.
Funded centrally the service provides MDT expertise free at
point of care to all patients in England. The objectives are:
1. To provide accurate clinical and molecular genetic diagnosis
and sub-classification of Stickler Syndrome for patients and
families.
2. To develop a central patient registry and repository of data
for longitudinal outcomes of all patients with Stickler syndrome in
England to facilitate advancements in risk assessment, prophylaxis
and treatment of the long-term complications of this disorder.
Now in its 10th year, the Stickler Highly Specialised Service
(HSS) has assessed 1673 patients from 785 families. Using a
combination of accurate phenotyping and molecular genetic
analysis it is possible to identify the underlying genetic mutation
in over 95% of cases so that prophylactic retinopexy can be
offered to the high-risk sub-groups and reduce the risk of
blindness [Table 1]. The last 10 years have also seen the
emergence of an increasing array of sub-groups including
ocular-only and autosomal recessive variants through a variety
of molecular mechanisms [1].
This article summarises ten selected briefcase histories from the
national dataset with key learning points from each.
CASE STUDY 1
The proband presented with Treacher Collins syndrome (TCS) at
birth. Reconstructive operations were performed during childhood
to correct facial anomalies which included cleft palate, micro-
gnathia, microtia and maxillary hypoplasia (Fig. 1). Audiometry
demonstrated mixed conductive and sensorineural hearing
defects. The father, although not formally diagnosed with TCS,
had malar flattening associated with bilateral lower lid malforma-
tions including bilateral agenesis of lower canaliculi and coloboma
of the left lower lid.
The possibility of Stickler syndrome was not entertained until
the age of 15 years when the proband attended the Stickler clinic
as part of a screening process of maternal relatives for Stickler
syndrome. His mother, uncle, maternal grandfather, and younger
sister all exhibited the beaded vitreous phenotype characteristic of
type 2 Stickler syndrome in association (Fig. 2b) with high myopia,
midfacial hypoplasia, and mid-line clefting. The proband also
exhibited the type 2 beaded vitreous phenotype (which is not a
feature of TCS) and high myopia. Shortly after diagnosis, the
patient developed left retinal detachment with multiple breaks
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which was successfully reattached. No prophylaxis was given to
the fellow eye. Eight years later he developed a right retinal
detachment with multiple breaks through 360 degrees which was
successfully re-attached.
DNA analysis identified a single nucleotide substitution
(c.1874G > T) in exon 19 of COL11A1, predicted to result in an
amino acid substitution of a triple helix glycine (p.Gly625Val) in
the α1 chain of type XI procollagen (type 2 Stickler syndrome).
Key learning points
1. Vitreous phenotyping was key to the clinical diagnosis in an
unusual compound phenotype, which was atypical for
either disorder.
2. Risk of bilateral retinal detachment in Type 2 Stickler
syndrome.
CASE STUDY 2
The 20-month-old proband was referred from paediatric ophthalmol-
ogy services with what was thought to be congenital cataract in both
eyes. Both parents and his older sibling had normal vitreous
phenotypes and there was no family history of cataract, retinal
detachment or eye disease. On examination both eyes were
hypotonous and the child was found to have right total cataract
secondary to longstanding fixed funnel retinal detachment and also a
total retinal detachment in fellow (left) eye but in which it was
possible to visualise the membranous type 1 vitreous anomaly
(Fig. 2a) when examined under anaesthesia. On the basis of the
vitreous phenotype, fluorescent sequencing of COL2A1 was initiated
and confirmed a heterozygous base change in exon 42 resulting in
premature termination codon and haploinsufficiency typical of type 1
Stickler syndrome. Both right and left retinal detachments were
successfully repaired but there has been no significant functional
recovery of vision in the seven years of subsequent follow-up.
Key learning points
1. Type 1 Stickler syndrome high risk of childhood blindness––in
this case, bilateral Giant Retinal Tear detachments occurring in
an infant under one year of age.
2. In sporadic cases, vitreous phenotype can be key in making
diagnosis and directing subsequent laboratory analysis
(Fig. 2a,b)
CASE STUDY 3
The proband was aged 8 years and referred from paediatric
ophthalmology services for consideration of surgery for an incidental
finding of poor vision and unilateral cataract in his left eye. The
proband had not reported or noticed the unilateral visual loss but had
been documented to have a clear lens one year previously.
Fig. 1 Case 1. Double heterozygosity – combined Treacher Collins
syndrome inherited from father and type 2 Stickler syndrome
inherited from mother. Type 2 Stickler syndrome vitreous phenotype
(see Fig. 2).
Fig. 2 Vitreous phenotypes – pathognomonic of Stickler syn-
drome. Top 2a Schematic and slit-lamp illustration: Membranous
congenital vitreous anomaly [Haploinsufficiency mutations
COL2A1]. Bottom 2b. Schematic and slit-lamp illustration: Beaded
congenital vitreous anomaly [COL11A1 dominant-negative muta-
tions]. Reproduced with permission from [1].
Fig. 3 Case 3. 210 degrees Giant Retinal Tear identified at EUA in otherwise asymptomatic 8 yr old child.
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Examination revealed, in addition to the membranous type 1
vitreous anomaly, secondary retinogenic lens epithelial metaplasia
[2, 3] and heavy pigment dispersion in the vitreous cavity. During
examination under anaesthesia he was found to have a peripheral
retinal detachment with a 210 degrees Giant Retinal Tear in one
eye and four peripheral tears in the fellow eye. (Fig. 3)
On the basis of the vitreous phenotype fluorescent sequencing of
COL2A1 was initiated and confirmed a heterozygous deletion of two
nucleotides in exon 52 of the COL2A1 gene resulting in a frameshift
and haploinsufficiency, typical of type 1 Stickler syndrome.
Key learning points
1. Type 1 Stickler syndrome carries a high risk of bilateral
retinal detachment––incidental finding of a Giant Retinal
tear in one eye and multiple retinal breaks in the fellow eye.
2. Examination under anaesthesia may be required to examine
the peripheral retina to the ora serrata in a child.
3. Vitreous phenotype is key in making diagnosis and directing
subsequent laboratory analysis.
CASE STUDY 4
The proband was born with a cleft palate but no associated hearing
loss and no family history of retinal detachment, cleft palate or
deafness. At age three, he was found to be holding books very close
and so-referred to ophthalmology services where cycloplegic
refraction revealed bilateral highly myopic astigmatism (−11.00/
−3.50 × 180) but was advised the risk of retinal detachment was
“low”. Six months later he re-presented with an inoperable giant
retinal tear detachment and despite surgery deteriorated to
phthisis bulbi.
At age 6 he was referred by clinical genetics to the national
Stickler Syndrome Diagnostic Service but because of severe
persistent photophobia from his blind eye, slit-lamp examination
was not possible. Targeted analysis of the known Stickler genes was
carried out, failing to identify any pathogenic mutation in COL2A1,
COL11A1, COL11A2, COL9A1, COL9A2, COL9A3 in the coding regions
of these genes. An examination under anaesthesia was arranged
which allowed visualisation of the type 1 membranous vitreous
anomaly in the non-phthisical eye in addition to a 90-degree giant
retinal tear which was successfully secured with 360 prophylactic
cryoretinopexy. On the basis of the vitreous phenotype a diagnosis
of Type 1 Stickler syndrome was made and a whole gene sequence
analysis including all introns of COL2A1 was carried out which
identified a deep intronic (c.2194-101 G > T in intron 33) sequence
variant of unknown clinical significance. In silico analysis suggested it
created a de novo donor splice site in the intron.
Functional analysis
Both normal and variant DNA sequences were amplified and
cloned to create minigenes, which were subsequently transfected
and expressed in an ophthalmic cell line in vitro before harvesting
and analysing RNA by RT-PCR. This showed that the variant cDNA
contained extra sequence corresponding to intron 33 and use of a
de novo donor splice site created by the c.2194-101 G > T variant
which resulted in the addition of 136 nucleotides to the mRNA
including a premature termination codon (Fig. 4).
Key learning points
1. Deep intronic mutations may still be pathogenic, but require
supplementary functional analysis to confirm pathogenicity.
2. Deep intronic mutations will be missed by conventional
exome panel analysis–vitreous phenotyping was key to
directing whole gene sequencing and supplementary mini-
gene functional analysis
3. High risk of bilateral retinal detachment and blindness in
Type 1 Stickler Syndrome. Prophylaxis is key to preserving
vision in this sub-group.
CASE STUDY 5
The patient was born with a cleft palate. She was moderately
myopic and ocular examination demonstrated the membranous
vitreous anomaly and a clinical diagnosis of type 1 Stickler
syndrome were made. She did not demonstrate any signs of
skeletal dysplasia. Neither parent demonstrated any clinical signs
of Stickler syndrome. Genetic analysis confirmed a COL2A1
mutation, c.1597 C > T p.Arg533Ter in the child. Analysis of her
clinically normal parents demonstrated a low level of the same
mutation in the proband’s father. Quantitation by real-time PCR
indicated that approximately 8% of the father COL2A1 alleles in
lymphocyte DNA had the mutant sequence.
Key learning points
1. New mutations are relatively common in Type 1 Stickler
syndrome but mosaicism should be considered in appar-
ently “de novo” cases [4].
2. Vitreous phenotype key to diagnosis in a case of cleft palate
in the absence of both skeletal dysplasia and any family
history of Stickler syndrome.
CASE STUDY 6
The proband presented age 11, already blind in his right eye as a
result of retinal detachment, erroneously ascribed to retinal dialysis.
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Fig. 4 Case 4. Agarose gel electrophoresis showing that cDNA from
the variant (V) minigene larger than that from the normal (N)
minigene (left). cDNA sequencing showed that the variant
contained extra sequence corresponding to intron 33 and use of a
de novo donor splice site created by the variant, resulting in the
addition of 136 nucleotides to the mRNA including a premature
termination codon. Courtesy of Dr Allan Richards.
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Examination of the fellow eye established the presence of the type 1
membranous vitreous anomaly consistent with type 1 Stickler
syndrome and the diagnosis was confirmed on molecular genetic
analysis. The rationale and objectives of prophylaxis to the fellow eye
were discussed and the patient was listed for 360-degree prophylactic
retinopexy according to standard published protocols [5, 6]. Unfortu-
nately, surgery and theatre access were delayed by the COVID-19
pandemic and the child re-attended 5 months later with total loss of
vision and Giant Retinal Tear detachment in his remaining eye (Fig. 5).
His retinal detachment was successfully repaired but he has only
regained 6/12- corrected vision to date.
Key learning points
1. Retinal dialysis should not be confused with a Giant Retinal
Tear (GRT) - the pathogenesis and surgical management are
entirely different [7]. Although the oral disinsertion of a
retinal dialysis may exceed 90° the vitreous is of normal
architecture and characteristically remains attached to the
posterior flap so that the independent mobility typical of a
true giant retinal tear (GRT) is not a feature. Dialyses respond
very well to conventional scleral buckling techniques [8]
whereas a GRT will usually require an internal approach [9].
2. High risk of visual loss in Type 1 Stickler Syndrome.
Although GRTs can be successfully repaired, prophylaxis
rather than repair is key to preserving best vision in the high
risk sub-groups (Table 1), [5, 6, 10, 11].
3. Half of all patients with genetically confirmed type 1 Stickler
syndrome who experience retinal detachment suffer retinal
detachment in their second eye within four years of the first
eye [6].
CASE STUDY 7
The proband was delivered by Caesarean section at 35 weeks and
noted to have a cleft palate. There was a history of “blindness” in
the paternal grandmother and a midwife mentioned that cleft
palate and blindness “can sometime be associated”.
Two years later a full-term sibling was born by normal delivery
and without palate abnormality.
At age four, the proband was noted by nursery staff to be
holding books close and was found to be myopic at subsequent
refraction. After searching the internet, the mother was concerned
about possible Stickler syndrome in her eldest child and requested
a referral to the national service.
Concurrently, the father developed floaters and sought advice
at the local HES. No abnormality was detected on dilated fundal
examination and the patient reassured and discharged. The
possibility of Stickler syndrome volunteered by the patient and his
wife was dismissed on the basis of a normal facial phenotype.
On attendance and examination at the National Stickler Clinic,
vitreous phenotyping for the infants proved impossible but
examination of the father confirmed the type 1 vitreous anomaly
in addition to asymptomatic bilateral retinal detachments–a giant
retinal tear in his right eye and a localised horse-shoe tear
detachment in his left. Both retinal detachments were repaired.
At examination under anaesthesia both infants also exhibited the
type 1 vitreous anomaly and both were found to have retinal tears at
EUA. Fluorescent sequencing analysis of blood taken at EUA detected
a heterozygous change of a single nucleotide (c.2896-1 G>A) at the
intron 42/exon 43 boundary of the COL2A1 gene resulting in
abnormal splicing of the COL2A1 mRNA (data not shown)
Key learning points
1. Consider Stickler syndrome in any infant with cleft palate in
association with myopia.
2. Affected adults, as well as children, are susceptible to GRT
and prophylaxis should be considered in confirmed high risk
cases irrespective of age.
3. Facial phenotype is unreliable for diagnosis exclusion–
especially in adults and the ocular-only variants [1, 12, 13].
4. Examination of both parents may be valuable for any infant
in whom Stickler syndrome is suspected but in whom
vitreous examination is not possible.
CASE STUDY 8
Two young boys both with severe deafness were referred. Neither
parent was considered to show any signs of Stickler syndrome - their
father had a high arched palate and mild, asymptomatic high tone
hearing loss; the mother exhibited mild, asymptomatic hearing loss
and normal vitreous. The proband had been born with congenital
myopia (-7DS right and left), Pierre Robin sequence and profound
hearing loss (90 dB), for which he had been given bilateral cochlear
implants. His new-born brother (18 days old) also had Pierre Robin
sequence, and auditory brainstem assessment demonstrated no
recordable responses at over 95 dB.
Molecular genetic analysis of the gene for type 2 Stickler syndrome
(COL11A1) identified 2 variants. One was clearly pathogenic–a
frameshift mutation in exon 13; the other was a sequence variant
(c.991-24 A >G) in intron 8 of unknown significance (single allele
recorded on gnomAD v2.1.1, from 248,080 alleles sequenced).
In silico analysis of the second variant predicted the creation of
an alternative exon 9 acceptor splice site. Functional mini-gene
analysis showed that both the normal and mutant sequence
produced a small amount of exon skipping, which reflected that
exon 9 is alternatively spliced (expressed in different versions) in
different tissues. However, the full length mutant cDNA appeared
larger than the normal cDNA and contained an insertion of an
additional 23 bp at the start of exon 9 which corresponded to the
creation of a novel acceptor splice site, causing a shift in the
reading frame and a downstream premature termination codon.
Despite the normal acceptor splice site being present, functional
minigene analysis showed that this was not being utilised.
Because exon 9 is not expressed in all tissues, this mutation
would be naturally removed from those tissues and have no
effect, only being pathogenic in tissues where exon 9 is expressed.
Key learning points
1. Recessive mutations in the COL11A1 gene normally result in
fibrochondrogenesis––a severe (or even lethal) skeletal
dysplasia.
2. This case demonstrates that effects of some recessive
mutations in COL11A1 can be modified by alternative splicing
Fig. 5 Case 6. GRT – child with undiagnosed type 1 Stickler
syndrome, already blind in the fellow eye from retinal detachment.
[GRT, giant retinal tear]. Reproduced with permission from [1].
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and result in type 2 Stickler syndrome rather than fibrochon-
drogenesis. As with exon 2 in type 1 Stickler syndrome [12, 13]
so the natural alternative splicing of COL11A1 exon 9 modifies
the effect of such mutations reducing the severity of the
associated skeletal dysplasia [14].
3. Exon 9 of COL11A1 is expressed in Meckel’s cartilage [15] which
gives rise to the malleus and incus of the inner ear, in addition
to the anterior ligament of the malleus tympanic plate [16]
resulting in more severe hearing loss this sub-group of AR
Stickler syndrome [14].
4. Disease phenotypes from de novo pathogenic variants can be
modified by inherited recessive variants on the other allele
[14, 17].
CASE STUDY 9
The patient presented as the affected child of a mother already blind
as a result of retinal detachment in both eyes. She underwent bilateral
360-degree prophylactic retinopexy at the age of 12 and has retained
stable vision in both eyes over the subsequent 38 years.
She re-presented to the service aged 46 because of significant joint
pain with reduced mobility and walking with a stick. She had had
several steroid injections into her knee and hip joints with short lived
effects. She had not found medications to be helpful. She had been
working in a sedentary role but finding it difficult to attend work and
was in danger of losing her job. Co-morbid depression was evident.
X-rays demonstrated a skeletal dysplasia affecting her hips and knees
with associated degenerative changes. She was recommended for
joint replacement, starting with her hips.
A diagnosis of type 1 Stickler syndrome was made on the basis
of vitreous phenotype and confirmed on molecular genetic
analysis as a single base change at the exon 40/intron 40
boundary of the COL2A1 gene, c.2679+ 5 G > C, resulting in the
abolition of the splice donor site leading to aberrant splicing.
Key learning points
1. Patients with Stickler Syndrome can have skeletal abnorm-
alities including a Marfanoid habitus, short stature and chest
wall deformities.
2. The epiphyseal abnormalities most commonly cause
femoral head changes in the hip and femoral condyle
changes in the knee leading to early (4th-5th decade) joint
arthroplasty. Other joints and the spine can also be affected.
X-rays are indicated if there is joint pain.
3. Occasionally, platyspondyly (flattened vertebra) is misdiag-
nosed as vertebral fracture (osteoporosis).
4. No known disease modification is available but quality of life
can be improved with pain management, including
physiotherapy, and treatment of co-morbid sleep and mood
disturbances
5. Early education and support are essential for optimal quality
of life with appropriate education of employers and support
services with regards to diagnosis and prognosis [18].
CASE STUDY 10
The proband was referred aged three years with congenital high
myopia, having undergone cleft palate repair at age one. A diagnosis
of type 1 Stickler syndrome was made on the basis of vitreous
phenotype and confirmed on molecular genetic analysis. Three-
hundred-sixty degree prophylactic retinopexy was applied to both
eyes and she progressed well in normal schooling and partook in
various sporting activities including dancing and swimming. She
developed right hip pain whilst undergoing Duke of Edinburgh
Award training. Her examination demonstrated pes planus bilaterally
with pain around her hip consistent with a soft tissue Greater
Trochanteric Pain Syndrome. No X-ray was requested, given her age
and likely diagnosis. She was advised to take analgesia (paracetamol
and topical ibuprofen gel as necessary), supplied with tailored
exercises, use over-the-counter medial arch insoles and continue with
exercise. She completed her Award, cut back on weight-bearing
activities and her pain settled.
Key learning points
1. Joint hypermobility is more frequent in the Stickler
Syndrome and is associated with pes planus and soft tissue
pain, particularly around the ankle and knee. The wrist, base
of thumb, spine and hip can also be affected. Dislocations
can be associated with chronic pain.
2. The growing skeleton of the child affords an opportunity to
correct disadvantageous biomechanics such as pes planus
with education, orthotics and exercises.
3. Advice regarding sports should weigh up the social and
health advantages with the risk of joint and ocular injury.
Each case should be individually assessed. Usually, the
advantages of any activity outweigh the risks.
SUMMARY
Although genetic conditions may be thought of as rare, Stickler
syndrome is relatively common–the national service is seeing
approximately 70 new index referrals per year. At least 10 clinically
and genetically distinct sub-groups of Stickler syndrome are now
recognised and with accurate phenotyping and molecular genetic
analysis it is possible to identify the underlying genetic mutation in
over 95% of cases. Deep intronic mutations may still be pathogenic,
but will be missed by conventional exome panel analysis and will
require whole gene sequencing and supplementary functional
analysis to confirm pathogenicity. The vast majority that presents to
ophthalmologists will be from one of three autosomal dominant sub-
groups with a high associated risk of retinal detachment but the
diagnosis is often overlooked, especially in adults. In contrast to many
other blinding retinal conditions, blindness through giant retinal tear
detachment particularly in children is largely preventable provided
these high-risk groups are identified and appropriate evidence-based
prophylaxis offered.
SUMMARY LEARNING POINTS
1. The NHSE national specialist MDT service is commissioned
centrally and therefore “free” at point of care for patients
and families affected by Stickler syndrome.
2. In addition to diagnosis and stratification of their risk of
blindness it provides counselling and specialist adult and
paediatric, rheumatology and audiology assessment for all
patients as part of a one-stop MDT service.
3. Patients should be considered for referral to the service from
the following categories:
(i) Infants with a history of congenital myopia in association
with deafness
(ii) Infants born with cleft palate or Pierre Robin Sequence in
association with myopia
(iii) Infants with joint hypermobility and/or epiphyseal dysplasia
in association with myopia
(iv) Individuals suffering rhegmatogenous retinal detachment
with a family history of rhegmatogenous retinal detachment.
4. Isolated cleft palate is not it itself an indication for referral
unless associated with categories 3(i)-(iv) above.




NHSE central commissioning is just one example of the many
ways in which the NHS leads the rest of the world in healthcare. To
date, 1673 patients from 785 families with Stickler syndrome have
been assessed as part of the NHSE Highly Specialised Service and
well over 90% continue under annual review to help build an
increasingly powerful database from which to evaluate treatments
and outcomes of the long-term complications of this disorder.
For the laboratory molecular genetic analysis, deep intronic variants
missed by conventional exome panel analysis may still be pathogenic.
Next Generation Sequencing (NGS) can deliver rapid whole-genome
sequencing, but does not solve the problem of determining the
pathogenicity of such deep intronic variants. The NHSE HSS provides
supplementary functional analysis to substantiate pathogenicity in
such instances and is currently developing techniques by which this
functional analysis can be enhanced.
Summary
What is known about this topic
The Stickler syndromes form part of the spectrum of inherited
vitreoretinopathies and are the most common cause of retinal
detachment in childhood and the most common cause of familial
retinal detachment.
What this study adds
The NHSE national specialist MDT service is commissioned centrally
and therefore “free” at point of care for patients and families affected
by Stickler syndrome. In addition to diagnosis and stratification of
their risk of blindness it provides counselling and specialist adult and
paediatric, rheumatology and audiology assessment for all patients as
part of a one-stop MDT service. Patients should be considered for
referral to the service from the following categories:
● Infants with a history of congenital myopia in association
with deafness.
● Infants born with cleft palate or Pierre Robin Sequence in
association with myopia.
● Infants with joint hypermobility and/or epiphyseal dyspla-
sia in association with myopia.
● Individuals suffering rhegmatogenous retinal detachment
with a family history of rhegmatogenous retinal
detachment.
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